Indefinite Delivery Contract 12639524D0015

Award Date 2/14/24
Last Date to Order 2/13/29
Funding Federal Agency
Plant Protection and Quarantine
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV was awarded by the U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $740,000 single-award Indefinite Delivery Contract is for Oxford Nanopore's genomic sequencing consumables, including reagents, flow cells, and other sequencing accessories. Under a $13,248 Firm Fixed Price Delivery Order issued in January 2025, Oxford Nanopore will...
This Indefinite Delivery Contract was awarded by the U.S. Department of Agriculture (USDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $35,000,000 and a period of performance through May 25, 2025. Under this contract, Illumina provides a range of laboratory equipment, consumables, and services to support the USDA's research and diagnostic needs. This includes the provision of Illumina's NextSeq, NovaSeq,...
Pacific Biosciences of California, Inc. has been awarded a $13.5 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract by the USDA Agricultural Research Service to provide specialized scientific equipment, reagents, and services associated with the company's Sequel and Sequel II DNA/RNA sequencing platforms. This long-term contract vehicle allows the USDA to issue multiple delivery orders for PacBio's high-throughput, long-read sequencing systems, consumables, and...
This Indefinite Delivery Contract (IDC) was awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $243,308 single-award contract has a period of performance ending on June 4, 2013. Under this IDC, Illumina provides a range of genomic sequencing systems, consumables, and bioinformatics products to support research and...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Health and Human Services' Office of Acquisitions and Grants to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The BPA, valued at $66,990, is for the purchase of reagents and supplies for use with the MinION portable nanopore next-generation sequencing device. The contract has a single award structure and a total period of performance of 4 years, from September...
The U.S. Department of Agriculture's Agricultural Research Service (USDA ARS) awarded an Indefinite Delivery Contract (IDC) to Epoch Life Science Inc., a biotechnology company, to provide custom gene synthesis, site-directed mutagenesis, subcloning, and sequence verification services. This single-award IDC has a ceiling value of $300,000 and a period of performance from March 27, 2018 to April 1, 2021, with no set-aside designations. Through various firm-fixed price delivery orders issued...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency within the Department of Health and Human Services, to the prime contractor Transnetyx, Inc. The $30,000 BPA is for the provision of genotyping and genetic monitoring services, with a period of performance from March 2025 to February 2027. Transnetyx, a for-profit organization specializing in automated genotyping, DNA extraction,...
The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Psomagen Inc., a subsidiary of Macrogen, Inc., with a potential value of $500 million. The contract supports the Trans-Omics for Precision Medicine initiative through September 2033 by providing complex data analysis, integration, and management of large-scale genomic and health datasets. Specifically, the contractor will establish and operate the Centralized Omics Resource to perform...
The Department of Agriculture Animal and Plant Health Inspection Service Plant Protection and Quarantine awarded Functional Biosciences, Inc. a blanket purchase agreement to streamline procurement of DNA sequencing, gene synthesis, molecular biology and genomic services. The single award agreement has a potential value of $300,000 over five years to support plant protection and quarantine programs. Multiple call orders have been placed against the blanket purchase agreement for supplies such...
This indefinite delivery contract was awarded by the USDA Agricultural Research Service (ARS) Field Research Implementation and Information Delivery (FRIID) Pacific West Area to Azenta US Inc., doing business as Brooks Life Sciences Inc., for DNA sequencing services. The single-award IDIQ contract has a ceiling value of $337,920 and a period of performance through September 2028. Under this contract, Azenta has been issued two firm fixed price delivery orders valued at $15,360 each to provide...
  • 12639524D0015
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The key products and services being delivered under this federal contract IDV award are Sanger sequencing services provided by Psomagen Inc. to the U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) Plant Protection and Quarantine (PPQ) National Identification Service (NIS). Psomagen, a for-profit manufacturer of goods, holds a single-award IDV valued at $80,000 to provide these sequencing services, which support the agency's efforts to identify intercepted insects and other pests. Additionally, Psomagen has been awarded two firm fixed-price delivery orders off this IDV, valued at $10,000 and $8,000 respectively, to perform the Sanger sequencing work in Potomac, Maryland.

Psomagen also holds a larger, $500 million single-award IDV from the National Institutes of Health (NIH) National Heart, Lung and Blood Institute to establish and operate the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative, through which the company will provide multi-omics analysis, data integration, and informatics capabilities to enable precision medicine approaches for cardiovascular, lung, blood, and sleep disorders. These IDV awards demonstrate Psomagen's expertise in providing specialized sequencing services as well as large-scale omics data management for critical federal research programs.

Generated 3/13/25, 10:05 AM